Actively Recruiting
Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
Led by Medical University of Warsaw · Updated on 2024-09-19
90
Participants Needed
1
Research Sites
118 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability. The participants will be divided into 2 groups: with or without preemptive pregabalin administration.
CONDITIONS
Official Title
Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing sleeve gastrectomy with BMI over 40 or BMI over 35 with other health conditions
- Signed written informed consent to participate
You will not qualify if you...
- Patient refusal to participate
- Known allergies to the study medication
- Unable to understand or use the pain scoring scale
- Unable to use intravenous patient-controlled analgesia
- Changes in the planned extent of surgery during the procedure
- Revisional (repeat) operations
- End-stage organ failure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Szpital Kliniczny Dzieciatka Jezus
Warsaw, Warsaw, Poland, 02-005
Actively Recruiting
Research Team
P
Piotr Mieszczański, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here